AdvaMedDx announced this week that it has elected John Bishop, CEO of Cepheid, as the new chair of its board of directors. Before joining Cepheid in 2002, he was CEO and president of Vysis.
Additionally, AdvaMedDx has newly elected to its board Robert Greczyn, interim president and CEO of LipoScience, for the 2014-2015 term.